{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T21:18:04Z","timestamp":1783027084313,"version":"3.54.6"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ethnopharmacology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jep.2026.121876","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T06:56:28Z","timestamp":1779864988000},"page":"121876","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Integrating molecular dynamics and experimental validation reveals ShenQi granule stabilizes podocyte cytoskeleton by modulating Bax\/Bcl2-caspase-3 rheostat in IMN"],"prefix":"10.1016","volume":"370","author":[{"given":"Li-feng","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-ping","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-sheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-xiu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-ping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-ye","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jep.2026.121876_bib1","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1681\/ASN.0000000769","article-title":"Questions and caveats in antigen-defined membranous nephropathy","volume":"36","author":"Andeen","year":"2025","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jep.2026.121876_bib2","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1146\/annurev-med-050522-034537","article-title":"Novel antigens and clinical updates in membranous nephropathy","volume":"75","author":"Avasare","year":"2024","journal-title":"Annu. Rev. Med."},{"issue":"6","key":"10.1016\/j.jep.2026.121876_bib3","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1053\/j.ajkd.2013.05.005","article-title":"Efficacy and safety of traditional chinese medicine (Shenqi particle) for patients with idiopathic membranous nephropathy: a multicenter randomized controlled clinical trial","volume":"62","author":"Chen","year":"2013","journal-title":"Am. J. Kidney Dis."},{"issue":"7","key":"10.1016\/j.jep.2026.121876_bib4","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.3390\/cells11071095","article-title":"Activation of the renin\u2013angiotensin System disrupts the cytoskeletal Architecture of human urine-derived podocytes","volume":"11","author":"Erichsen","year":"2022","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.jep.2026.121876_bib5","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.cell.2017.07.029","article-title":"The PI3K pathway in human disease","volume":"170","author":"Fruman","year":"2017","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.jep.2026.121876_bib6","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.cell.2011.10.033","article-title":"Programmed cell death in animal development and disease","volume":"147","author":"Fuchs","year":"2011","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.jep.2026.121876_bib7","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.25122\/jml-2021-0227","article-title":"Nephroprotective effects of Candesartan Cilexetil against Cyclosporine A-induced nephrotoxicity in a rat model","volume":"15","author":"Ghafil","year":"2022","journal-title":"J Med Life"},{"issue":"21","key":"10.1016\/j.jep.2026.121876_bib8","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1056\/NEJMra1704560","article-title":"Phosphatidylinositol 3-Kinase, growth disorders, and cancer","volume":"379","author":"Goncalves","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.jep.2026.121876_bib9","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1053\/j.ajkd.2010.01.012","article-title":"Remission of membranous nephropathy after therapy with Astragalus membranaceus","volume":"55","author":"Leehey","year":"2010","journal-title":"Am. J. Kidney Dis."},{"issue":"9","key":"10.1016\/j.jep.2026.121876_bib10","first-page":"19","article-title":"Linking basement membrane and slit diaphragm in Drosophila nephrocytes","volume":"35","author":"Leroy","year":"2024"},{"key":"10.1016\/j.jep.2026.121876_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114383","article-title":"The PM2.5 component, benzo[b]fluoranthene, may contribute to the pathogenesis of membranous nephropathy by activating phosphoinositide 3-kinase\/protein kinase B pathway and causing podocyte pyroptosis","volume":"152","author":"Li","year":"2025","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.jep.2026.121876_bib12","article-title":"Circulating anti-nephrin antibody as permeability factor for inducing primary focal segmental glomerular sclerosis and minimal change disease","volume":"2","author":"Li","year":"2025"},{"key":"10.1016\/j.jep.2026.121876_bib13","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8832114","article-title":"Tacrolimus protects podocytes from apoptosis via downregulation of TRPC6 in diabetic nephropathy","volume":"2021","author":"Ma","year":"2021","journal-title":"J. Diabetes Res."},{"issue":"1","key":"10.1016\/j.jep.2026.121876_bib14","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s12882-025-04713-z","article-title":"Narrative review on decoding the crosstalk between lipid homeostasis and immune pathways in membranous nephropathy","volume":"27","author":"Ma","year":"2025","journal-title":"BMC Nephrol."},{"issue":"1","key":"10.1016\/j.jep.2026.121876_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-13978-1","article-title":"Innovative nanostructured lipid-particles of apocynin and clove oil tagged with Chitin oligosaccharide for amelioration of tacrolimus-induced nephrotoxicity","volume":"15","author":"Maghrabia","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jep.2026.121876_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2019.109468","article-title":"The PI3K\/Akt\/mTOR pathway in polycystic kidney disease: a complex interaction with polycystins and primary cilium","volume":"66","author":"Margaria","year":"2020","journal-title":"Cell. Signal."},{"key":"10.1016\/j.jep.2026.121876_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1412826","article-title":"Animal models of membranous nephropathy: more choices and higher similarity","volume":"15","author":"Pan","year":"2024","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.jep.2026.121876_bib18","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.1038\/s41467-019-11577-z","article-title":"A glomerulus-on-a-chip to recapitulate the human glomerular filtration barrier","volume":"10","author":"Petrosyan","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jep.2026.121876_bib19","series-title":"Anti-Nephrin Antibody: a Potential Biomarker of Minimal Change Disease","author":"Qiaoling","year":"2025"},{"issue":"1","key":"10.1016\/j.jep.2026.121876_bib20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s40001-025-02280-5","article-title":"SIRT1\/PGC-1alpha-mediated mitophagy participates the improvement roles of BMAL1 in podocytes injury in diabetic nephropathy: evidences from in vitro experiments","volume":"30","author":"Rui","year":"2025","journal-title":"Eur. J. Med. Res."},{"issue":"11","key":"10.1016\/j.jep.2026.121876_bib21","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.mayocp.2023.08.006","article-title":"Mayo Clinic consensus report on membranous nephropathy: proposal for a novel classification","volume":"98","author":"Sethi","year":"2023","journal-title":"Mayo Clin. Proc."},{"issue":"4","key":"10.1016\/j.jep.2026.121876_bib23","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.kint.2024.01.017","article-title":"A Neanderthal haplotype introgressed into the human genome confers protection against membranous nephropathy","volume":"105","author":"Voinescu","year":"2024","journal-title":"Kidney Int."},{"issue":"9","key":"10.1016\/j.jep.2026.121876_bib24","article-title":"Astragalus membranaceus formula for moderate-high risk idiopathic membranous nephropathy: a meta-analysis","volume":"102","author":"Wang","year":"2023","journal-title":"Medicine (Baltim.)"},{"issue":"7","key":"10.1016\/j.jep.2026.121876_bib25","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.614","article-title":"Membranous nephropathy: pathogenesis and treatments","volume":"5","author":"Wang","year":"2024","journal-title":"MedComm"},{"key":"10.1016\/j.jep.2026.121876_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115942","article-title":"Shenqi granule upregulates CD2AP and \u03b1-actinin4 and activates autophagy through regulation of mTOR\/ULK1 pathway in MPC5 cells","volume":"303","author":"Wei","year":"2023","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"10.1016\/j.jep.2026.121876_bib27","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12967-019-1792-8","article-title":"New risk score for predicting progression of membranous nephropathy","volume":"17","author":"Xiaofan","year":"2019","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.jep.2026.121876_bib28","article-title":"B cell and anti-PLA2R antibody-guided rituximab therapy in idiopathic membranous nephropathy: a prospective multi-center cohort study in the East Coastal Region of China","volume":"16","author":"Xu","year":"2025","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.jep.2026.121876_bib29","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00253-019-10257-8","article-title":"Targeting PI3K\/AKT\/mTOR-mediated autophagy for tumor therapy","volume":"104","author":"Xu","year":"2020","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"5","key":"10.1016\/j.jep.2026.121876_bib30","first-page":"69","article-title":"The regulatory effects of the Qi-tonifying, blood-activating and dampness-resolving formula on \u03b1-actinin-4 and CD2AP in podocyte peritubular membrane proteins in rats with a passive model of Heymann nephritis","volume":"53","author":"Yong","year":"2019","journal-title":"J. Tradit. Chin. Med."},{"issue":"2","key":"10.1016\/j.jep.2026.121876_bib31","first-page":"319","article-title":"The effects of the Qi-tonifying, blood-activating and dampness-resolving formula and its components on the Th17\/Treg ratio in peripheral blood of rats with passive heymann nephritis","volume":"35","author":"Yong","year":"2024","journal-title":"Shizhen Journal of Traditional Chinese Medicine"},{"issue":"18","key":"10.1016\/j.jep.2026.121876_bib32","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1097\/CM9.0000000000001565","article-title":"Association of anti-phospholipase A2 receptor antibody with the efficacy of traditional Chinese medicine (Shenqi particle) for patients with idiopathic membranous nephropathy: a prospective, cohort clinical study","volume":"134","author":"Zhang","year":"2021","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"10.1016\/j.jep.2026.121876_bib33","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s12882-025-04123-1","article-title":"CIAPIN1 attenuates ferroptosis via regulating PI3K\/AKT pathway in LPS-induced podocytes","volume":"26","author":"Zhang","year":"2025","journal-title":"BMC Nephrol."}],"container-title":["Journal of Ethnopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874126007282?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874126007282?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T20:32:03Z","timestamp":1783024323000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378874126007282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":32,"alternative-id":["S0378874126007282"],"URL":"https:\/\/doi.org\/10.1016\/j.jep.2026.121876","relation":{},"ISSN":["0378-8741"],"issn-type":[{"value":"0378-8741","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrating molecular dynamics and experimental validation reveals ShenQi granule stabilizes podocyte cytoskeleton by modulating Bax\/Bcl2-caspase-3 rheostat in IMN","name":"articletitle","label":"Article Title"},{"value":"Journal of Ethnopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jep.2026.121876","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"121876"}}